T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Comfort Systems
FIX
$61.2B
| $41.9M | 0.01% |
1,287,639
-1,180
| -0.1% | -$37.6K |
|
852
Fortinet
FTNT
$118B
| $41.9M | 0.01% |
6,623,870
-10,801,200
| -62% | -$69.9M |
|
|
PARA
853
DELISTED
Paramount Global Class B
PARA
| $41.6M | 0.01% |
764,581
-2,620
| -0.3% | -$142K |
|
854
J.M. Smucker
SJM
$12.7B
| $41.6M | 0.01% |
272,778
-2,251
| -0.8% | -$299K |
|
855
Kosmos Energy
KOS
$1.49B
| $41.5M | 0.01% |
7,622,767
+364,501
| +5% | +$2.06M |
|
856
Dime Commercial Bancshares
DCOM
$1.81B
| $41.5M | 0.01% |
1,461,970
+465,857
| +47% | +$13.8M |
|
857
Clorox
CLX
$12.8B
| $41.4M | 0.01% |
299,346
+1,982
| +0.7% | +$257K |
|
|
UAM
858
DELISTED
Universal American Corp
UAM
| $40.9M | 0.01% |
5,401,746
+1,948,587
| +56% | +$15.1M |
|
859
Maximus
MMS
$2.85B
| $40.8M | 0.01% |
736,100
+5,730
| +0.8% | +$309K |
|
860
Ulta Beauty
ULTA
$22.9B
| $40.5M | 0.01% |
166,341
+86,477
| +108% | +$18.8M |
|
861
Manhattan Associates
MANH
$11.2B
| $40.3M | 0.01% |
628,831
+27,008
| +4% | +$1.68M |
|
862
CubeSmart
CUBE
$9.28B
| $40.2M | 0.01% |
1,301,456
+138,536
| +12% | +$4.32M |
|
|
RAVN
863
DELISTED
Raven Industries Inc
RAVN
| $39.8M | 0.01% |
2,099,244
-45,600
| -2% | -$797K |
|
|
NATL
864
DELISTED
National Interstate Corporation
NATL
| $39.6M | 0.01% |
1,309,306
-24,654
| -2% | -$756K |
|
865
HP
HPQ
$26.8B
| $39.6M | 0.01% |
3,155,076
+6,330
| +0.2% | +$78.8K |
|
|
MRC
866
DELISTED
MRC Global
MRC
| $39.4M | 0.01% |
2,772,750
+25,460
| +0.9% | +$353K |
|
|
MNDT
867
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $39.3M | 0.01% |
2,388,503
+2,342,410
| +5,082% | +$37.9M |
|
868
Expedia Group
EXPE
$39.1B
| $39.3M | 0.01% |
369,716
+162,867
| +79% | +$17.7M |
|
|
CSBK
869
DELISTED
Clifton Bancorp Inc.
CSBK
| $39.2M | 0.01% |
2,601,394
-2,200
| -0.1% | -$32.9K |
|
|
KAMN
870
DELISTED
Kaman Corp
KAMN
| $39.2M | 0.01% |
921,911
-11,840
| -1% | -$499K |
|
871
Pultegroup
PHM
$24.6B
| $39M | 0.01% |
2,001,029
-12,520
| -0.6% | -$232K |
|
|
MPSX
872
DELISTED
Multi Packaging Solutions Intl.
MPSX
| $38.9M | 0.01% |
2,910,870
+1,124,330
| +63% | +$17.5M |
|
873
Perdoceo Education
PRDO
$1.96B
| $38.8M | 0.01% |
6,524,680
-280,900
| -4% | -$1.53M |
|
874
National Healthcare
NHC
$3.47B
| $38.8M | 0.01% |
598,829
-21,700
| -3% | -$1.38M |
|
875
VF Corp
VFC
$5.73B
| $38.7M | 0.01% |
668,204
-6,513
| -1% | -$385K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.